Lifeline Biotechnologies
Reno
About Lifeline Biotechnologies
Lifeline Biotechnologies, Inc., a medical technology company, develops diagnostic equipment for the prevention, early diagnosis, and quick recovery of ailments. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, permitting the physician to visualize the interior aspects of the breast; and Ovascope, an endoscope to visualize the ovarian surface in the search for cancer. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is based in Reno, Nevada with operations in Europe.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $200.0K
- Funding stage: IPO
- Last round: Post-IPO Debt (Oct 2009)
- Ticker: otcpink:LLBO
- Website: lbti.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Information Technology, Medical
Canonical: https://fsome.com/organization/lifeline-biotechnologies-313386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.